Literature DB >> 23095431

Empowering people with diabetes: improving perceptions and outcomes with technical advances in insulin pens.

David Oyer1, Marcus Niemeyer, Alan Moses.   

Abstract

For people with diabetes treated with insulin, the development of insulin pens has led to important advantages compared with the use of vials and syringes. Insulin pens are associated with improved ease of use, user confidence, treatment satisfaction, and quality of life compared with vials and syringes. Continual improvements to insulin pen designs to further enhance usability and improve patient perceptions may help to lower patients' resistance to initiating insulin therapy and further improve treatment adherence. This article reviews recent developments in prefilled insulin pens that may assist health care professionals when considering insulin-delivery devices to recommend to their patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23095431     DOI: 10.3810/pgm.2012.09.2587

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  3 in total

1.  Real-world assessment of glycemic control after V-Go® initiation in an endocrine practice in the southeastern United States.

Authors:  Barry R Johns; Thomas C Jones; John H Sink; Catherine E Cooke
Journal:  J Diabetes Sci Technol       Date:  2014-05-25

Review 2.  Half-Unit Insulin Pens: Disease Management in Patients With Diabetes Who Are Sensitive to Insulin.

Authors:  David C Klonoff; Irina Nayberg; Udo Stauder; Hamid Oualali; Catherine Domenger
Journal:  J Diabetes Sci Technol       Date:  2016-11-28

Review 3.  Biosimilar insulins: a European perspective.

Authors:  J H DeVries; S C L Gough; J Kiljanski; L Heinemann
Journal:  Diabetes Obes Metab       Date:  2014-11-27       Impact factor: 6.577

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.